Brief: Think Research Corp Expands Original $6.4 Mln Contract With Pharmaceutical Company By About $3.5 Mln
Feb 13 (Reuters) - Think Research Corporation THNK.V :
* THINK RESEARCH CORPORATION- HAS EXPANDED ITS ORIGINAL $6.4
MILLION CONTRACT WITH A GLOBAL PHARMACEUTICAL COMPANY BY
APPROXIMATELY $3.5 MILLION
Source text for Eikon: ID:nCNWCSDhma
Further company coverage: THNK.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Think Research
See all newsBrief: Think Research Announces Agreement For Subsequent Advance Under Existing Convertible Facility
Brief: Think Research Announces Agreement For Subsequent Advance Under Existing Convertible Facility
Canada Research Roundup: Bank of Montreal, Scotiabank, Transalta Renewables
Brief: Think Research Corporation Announces Record Second Quarter 2023 Results
Brief: Think Research Announces Bridge Loan